Clinical Trials Directory

Trials / Unknown

UnknownNCT03908359

Comparison of the Effect of Minimal Invasive Lens Surgery and Traditional Cataract Surgery

Comparison of the Effect of Minimal Invasive Lens Surgery and Traditional Cataract Surgery for Treating Congenital Cataracts

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Sun Yat-sen University · Academic / Other
Sex
All
Age
1 Month – 24 Months
Healthy volunteers
Not accepted

Summary

Previously, the investigators have developed a minimal invasive lens surgery in the purpose of reduce post-operative complications of congenital cataract. This prospective, randomized controlled study aims at comparing the prognosis of the minimal invasive lens surgery and the traditional cataract surgery for treating congenital cataracts.

Detailed description

Patients with congenital cataract that requires surgical intervention are enrolled. Then the participants are assigned to two groups: Group I: the participants receive a minimal invasive lens surgery, while in Group II, the participants receive a traditional cataract surgery. A secondary intraocular lens implantation is performed when the patient is two years old for both Group I and Group II. Investigators then compare the visual acuity, incidence of high intraocular pressure, incidence of visual axis opacification, uveitis and iris/pupil abnormality between two groups, to evaluate and compare the prognosis of minimal invasive lens surgery and traditional cataract surgery for treating congenital cataracts.

Conditions

Interventions

TypeNameDescription
PROCEDUREtraditional cataract surgeryACCC+ I/A + PCCC + Anti-vit: anterior continuous capsulorhexis + irrigation/aspiration + posterior capsulorhexis + anterior vitrectomy
PROCEDUREminimal invasive lens surgeryWe decreased the size of the capsulorhexis opening to 1.0-1.5 mm in diameter. Then we moved the location of the capsulorhexis to the peripheral area of the lens instead of the central area. A 0.9 mm phacoemulsification probe was used to remove the lens contents and/or cortical opacities.

Timeline

Start date
2019-01-01
Primary completion
2023-11-01
Completion
2023-12-01
First posted
2019-04-09
Last updated
2022-04-27

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03908359. Inclusion in this directory is not an endorsement.